MedPath
NMPA Approval

Disitamab Vedotin For Injection

国药准字S20210017

June 8, 2021

Drug Information

注射用维迪西妥单抗

爱地希

注射剂

60mg/支

生物制品

June 8, 2021

Company Information

Applicant Company

中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号

Manufacturing Company

中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用维迪西妥单抗 - NMPA 批准文号 | MedPath